Prenetics Global Limited (PRENW)
USD 0.01
(19.0%)
USD 0.01
(19.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -62.72 Million USD | 67.07% |
| 2022 | -190.45 Million USD | -9.45% |
| 2021 | -174.01 Million USD | -8760.85% |
| 2020 | -1.96 Million USD | 90.28% |
| 2019 | -20.19 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -8.56 Million USD | 55.02% |
| 2024 Q2 | -10.72 Million USD | -25.14% |
| 2023 Q1 | -10.97 Million USD | -782.47% |
| 2023 FY | -62.72 Million USD | 67.07% |
| 2023 Q3 | -13.57 Million USD | 37.77% |
| 2023 Q2 | -21.8 Million USD | -98.73% |
| 2023 Q4 | -19.04 Million USD | -40.36% |
| 2022 Q2 | -144.17 Million USD | -337.09% |
| 2022 Q1 | -32.98 Million USD | 61.53% |
| 2022 Q4 | 1.6 Million USD | 110.79% |
| 2022 FY | -190.45 Million USD | -9.45% |
| 2022 Q3 | -14.89 Million USD | 89.67% |
| 2021 Q2 | -9.77 Million USD | -609.77% |
| 2021 FY | -174.01 Million USD | -8760.85% |
| 2021 Q1 | 1.91 Million USD | 132.65% |
| 2021 Q4 | -85.74 Million USD | -6.63% |
| 2021 Q3 | -80.41 Million USD | -722.84% |
| 2020 Q2 | -4.68 Million USD | -655.79% |
| 2020 Q1 | -620.31 Thousand USD | 0.0% |
| 2020 FY | -1.96 Million USD | 90.28% |
| 2020 Q4 | -5.87 Million USD | -163.54% |
| 2020 Q3 | 9.24 Million USD | 297.11% |
| 2019 FY | -20.19 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Bionano Genomics, Inc. | -232.49 Million USD | 73.021% |
| Star Equity Holdings, Inc. | -1.54 Million USD | -3951.93% |
| CareDx, Inc | -190.28 Million USD | 67.037% |
| Exact Sciences Corporation | -204.14 Million USD | 69.275% |
| Exagen Inc. | -23.68 Million USD | -164.781% |
| Inotiv, Inc. | -105.14 Million USD | 40.343% |
| Guardant Health, Inc. | -479.44 Million USD | 86.918% |
| Biodesix, Inc. | -52.14 Million USD | -20.285% |
| BioNexus Gene Lab Corp. | -2.62 Million USD | -2285.806% |
| Precipio, Inc. | -5.85 Million USD | -971.653% |
| iSpecimen Inc. | -11.09 Million USD | -465.106% |
| Natera, Inc. | -434.8 Million USD | 85.574% |
| Aspira Women's Health Inc. | -16.69 Million USD | -275.817% |
| Standard BioTools Inc. | -74.65 Million USD | 15.983% |
| 23andMe Holding Co. | -666.7 Million USD | 90.592% |
| Castle Biosciences, Inc. | -57.46 Million USD | -9.15% |
| Personalis, Inc. | -108.29 Million USD | 42.081% |
| Aclaris Therapeutics, Inc. | -88.48 Million USD | 29.11% |
| Applied DNA Sciences, Inc. | -9.94 Million USD | -530.577% |
| OpGen, Inc. | -32.66 Million USD | -92.001% |
| T2 Biosystems, Inc. | -50.07 Million USD | -25.255% |
| Myriad Genetics, Inc. | -112 Million USD | 43.997% |
| ICON Public Limited Company | 612.33 Million USD | 110.243% |
| NeoGenomics, Inc. | -87.96 Million USD | 28.697% |
| Star Equity Holdings, Inc. | -1.54 Million USD | -3951.93% |
| IDEXX Laboratories, Inc. | 845.04 Million USD | 107.423% |
| RadNet, Inc. | 3.04 Million USD | 2160.574% |
| MDxHealth SA | -43.1 Million USD | -45.531% |
| Psychemedics Corporation | -4.15 Million USD | -1409.963% |
| Illumina, Inc. | -1.16 Billion USD | 94.597% |
| Check-Cap Ltd. | -17.56 Million USD | -257.035% |
| Twist Bioscience Corporation | -208.72 Million USD | 69.949% |
| DarioHealth Corp. | -59.42 Million USD | -5.548% |
| Fulgent Genetics, Inc. | -167.82 Million USD | 62.625% |
| Sera Prognostics, Inc. | -36.24 Million USD | -73.07% |
| ENDRA Life Sciences Inc. | -10.06 Million USD | -523.482% |
| OPKO Health, Inc. | -188.86 Million USD | 66.789% |
| Medpace Holdings, Inc. | 282.81 Million USD | 122.179% |
| Neogen Corporation | -9.42 Million USD | -565.788% |
| Intelligent Bio Solutions Inc. | -10.15 Million USD | -517.558% |
| Prenetics Global Limited | -62.72 Million USD | -0.0% |
| Mainz Biomed B.V. | -26.29 Million USD | -138.533% |
| bioAffinity Technologies, Inc. | -7.93 Million USD | -690.271% |
| Trinity Biotech plc | -24.01 Million USD | -161.154% |
| Neuronetics, Inc. | -30.18 Million USD | -107.771% |
| Sotera Health Company | 51.37 Million USD | 222.088% |
| bioAffinity Technologies, Inc. | -7.93 Million USD | -690.271% |